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 The timeline of follicle-enclosed oocyte growth and development is not known. 
To study this, mature female zebrafish, Danio rerio, were injected intraperitoneally with 
the marker trypan blue (TB). Ovaries were removed at different time post injection. Then, 
oocyte diameter and TB uptake were determined from brightfield and fluorescence 
microscopy images, respectively. TB uptake increased steadily up to 48 hours post 
injection and declined subsequently. In Tg(fli1:EGFP)y1 zebrafish that express green 
fluorescent protein in endothelial cells, ovarian blood vessel diameter was greater in 
larger oocytes and unaffected by in vitro treatments with vasoactive agents. In the 
transparent zebrafish, casper, oocytes naturally cycled between growth and regression in 
vivo. Exogenous estradiol and tamoxifen both disrupted the cycle and maintained ovaries 
in the regressed phase. Surprisingly, stopping the hormone treatment, restored the natural 
cycle. Together, these studies provide the foundation and tools for future experiments on 
oocyte development in zebrafish. 
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 Oogenesis is a dynamic process that defines the various stages of follicle-enclosed 
oocyte development leading to the formation of a mature egg (Lessman, 1999, 2009; 
Lubzens et al., 2010; Selman, 1993; Selman and Wallace, 1983; Wallace and Selman, 
1985) (Fig. 1). Several studies provide extensive information on the structural 
development of follicle-enclosed oocytes and the role of various ovarian cells involved in 
teleost oogenesis (Davail et al., 1998; Droller and Roth, 1966; Shaner et al., 2004; 
Wallace and Selman, 1985). Further, these studies also provide details on the role of 
hormones in follicle-enclosed oocyte development.  
 In teleost fish, follicle-enclosed oocyte development starts with the 
previtellogenic phase (stages 1 and 2) and continues with the vitellogenic phase (stage 3). 
During the vitellogenic phase, the yolk precursor, vitellogenin, and other nutrients are 
incorporated and this leads to significant increase in the size of the follicle-enclosed 
oocyte (Clelland and Peng, 2009; Lessman, 1999, 2009; Lubzens et al., 2010; Matsuda et 
al., 2011; Selman and Wallace, 1983). Further growth of the follicle-enclosed oocyte 
results in its meiotic maturation followed by ovulation and oviposition which prepares the 
female gamete for fertilization (Fig. 1) (Lessman, 2009; Lubzens et al., 2010; Selman, 
1993). However, the time course of ovarian follicle development and vitellogenin uptake 
during the vitellogenic phase is not completely known.   
 Vitellogenic phase includes the production of vitellogenin (Lessman, 2009; 
Polzonetti-Magni et al., 2004) and its incorporation into the follicle-enclosed oocyte 
together with lipids and vitamins (Lubzens et al., 2010). Vitellogenin is a bulky 
phospholipoglycoprotein (250-600KDa) molecule found in female teleosts and other 
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vertebrates that lay yolk-filled eggs. Vitellogenin is mainly synthesized in the liver, and 
in small amounts in other organs such as the ovary (Lubzens et al., 2010; Wang et al., 
2005). After synthesis, vitellogenin reaches the ovaries via the blood stream. Follicle-
enclosed oocytes take up vitellogenin by receptor mediated endocytosis. The endocytic 
vesicles fuse with lysosomes to form yolk globules (Fig. 2), which have a crystalline core 
of lipovitellin and phosvitin that have been processed from the endocytosed vitellogenin 
(Lessman, 2009; Okumura et al., 2002; Wallace and Selman, 1985, 1990). However, the 
specific time course for vitellogenin uptake and incorporation during development of the 
follicle-enclosed oocyte is not known.  
 Uptake of vitellogenin into follicle-enclosed oocytes in vivo occurs in an intact 
ovarian follicle that consists of a layer of follicle cells surrounding the oocyte, which in 
turn is surrounded by a stromal layer of theca cells and an outer layer of epithelial cells 
(Fig. 3). The follicle and theca cells are involved in the synthesis of steroid hormones 
(Fig. 3). The ovarian follicle is surrounded by blood vessels, which assist in transporting 
vitellogenin to the follicle for uptake into oocytes. The effect of steroid hormones or 
other neurotransmitters secreted during the oocyte development on follicle angiogenesis 
has not been studied in zebrafish.  
 Estradiol is a major hormone involved during the vitellogenic phase in the 
development of the follicle-enclosed oocyte (Clelland and Peng, 2009; Lessman, 1999; 
Lessman and Habibi, 1987; Lubzens et al., 2010; Miura et al., 2007). The primary role of 
estradiol is to control production of vitellogenin from the liver (Clelland and Peng, 2009). 
In addition, estradiol may have effects on yolk formation and proliferation of follicle-
enclosed oocytes as shown using in vitro experiments (Khoo, 1979; Miura et al., 2007), 
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but the effects may not be directly induced by estradiol (Cerda et al., 1998). However, the 
role of estradiol in oocyte development and its specific effects on the various stages of 
oocyte development have not been well studied in zebrafish. 
 Based on the above, the current understanding of follicle-enclosed oocyte 
development is especially limited in three major aspects and these are given as the major 
research aims indicated below:  
(1) determine the time-course of vitellogenin uptake in follicle enclosed oocytes of 
different size classes, 
 (2) determine the relationship between ovarian vascular development and development 
of follicle-enclosed oocytes and, 
(3) determine the effect of estradiol in the development of follicle-enclosed oocytes.  
 These issues remain largely unexplored in zebrafish (Danio rerio), even though 
zebrafish are touted as an important model organism. Hence, this study utilized zebrafish 
to help rectify this discrepancy in this important animal model.  Zebrafish is a tropical 
fish, native to India and Burma. Adult zebrafish are 40 to 50 mm long and weigh up to 
1.5 g. Zebrafish are used extensively in genetic, general and developmental biology 
research (Levi et al., 2009; Segner, 2009; Spitsbergen et al., 2009; Spitsbergen and Kent, 
2003; Tong et al., 2004), particularly because developing embryos can be observed 
readily through the transparent egg chorion (Laale, 1977). Also, zebrafish genome is 
sequenced and available online (http://www.ncbi.nlm.nih.gov/genome?term=daniorerio).  
 Ovarian development in zebrafish is asynchronous, where all stages of follicle 
development are present without a dominant population (Lessman, 1999; Wallace and 
Selman, 1980). In asynchronous ovulators, also called batch spawners, yolked oocytes 
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ovulate and mature into eggs in several batches during the spawning season. Thus, 
zebrafish produce small batches of eggs almost daily, and a large number of eggs (>150 
eggs) are produced every 5 to 10 days. Zebrafish embryos hatch in about 3 days at 28°C 
(Ankley and Johnson, 2004). These characteristics differ from that of other teleost fish 
such as, killifish, trout, and medaka (Ankley and Johnson, 2004; Lessman and Habibi, 
1987; Selman and Wallace, 1983; Tong et al., 2004; Wallace and Selman, 1985). Thus, 
studies of the timeline of follicle-enclosed oocyte development, vascular development 
and the effect of estradiol in zebrafish will add to our understanding of the reproductive 
biology of this important model organism.  
 Establishing the time course of vitellogenin endocytosis in various size classes of 
follicle-covered oocytes requires a marker that allows visualization of uptake by the 
zebrafish oocyte. Trypan blue (TB) is a vital stain that is blue under brightfield 
conditions. TB can also bind to proteins, and under these conditions fluoresces red when 
excited with green light. The dye is generally used to distinguish live from dead cells due 
to its inability to enter most live cells. Thus, under bright field conditions, TB-stained 
dead cells appear blue. Yet, exposing live vitellogenic ovarian follicles to TB causes its 
incorporation into oocytes (Anderson and Telfer, 1970; Danilchik and Denegre, 1991). In 
addition, in these follicles, TB is also present between epithelial cells, suggesting that the 
dye follows the path used by vitellogenin (Anderson and Telfer, 1970) through the 
various layers of the ovarian follicle. Though the studies have been done using insect 
(Anderson and Telfer, 1970) and frog oocytes (Danilchik and Denegre, 1991), the rapid 
uptake of TB from the maternal blood circulation and its deposition in oocytes in a 
manner similar to vitellogenin, suggest that TB enters the follicle-covered oocyte with 
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vitellogenin. Preliminary data in zebrafish indicated that TB fluorescence was restricted 
to yolk vesicles with no detectable signal in the oocyte cytosol, and in resulting embryos 
the yolk cell fluoresces while the non-yolky portions do not fluoresce. 
 In addition, quantifying vascular development requires visualizing ovarian blood 
vessels. The Tg(fli1:EGFP)y1 transgenic zebrafish expresses the green fluorescent 
protein (GFP) in the vascular endothelium (Lawson and Weinstein, 2002). The EGFP 
expression is driven by the promoter for fli1, an endothelial marker that is present during 
vascular development in zebrafish. Preliminary experiments showed that ovarian vessels 
of Tg(fli1:EGFP)y1 zebrafish could be visualized by fluorescence microscopy.  
 Further, establishing changes in ovarian morphology requires visualizing them in 
the intact zebrafish. The casper double mutant zebrafish lacks all melanocytes and 
iridiophores and thus, is almost entirely transparent (White et al., 2008).  In adult female 
casper zebrafish, individual follicles can be easily observed. 
 Thus, in wild type and transgenic zebrafish models, TB was used to follow the 
development of follicle-enclosed oocytes and ovarian blood vessels. In addition, the 
transgenic and mutant zebrafish were also used to determine the role of hormones on 








 Adult wild-type (Danio rerio) were reared at 28°C on a 14 hr photoperiod cycle, 
and fed Tetramin daily, supplemented with freeze-dried brine shrimp (Artemia).  The 
water in the spawning tanks was changed daily. Male and female fish were housed 
together in the spawning tanks. Spawning was checked daily and embryos were collected.  
 In addition, two additional zebrafish lines obtained as a gift from Dr. Michael R. 
Taylor, St. Jude Children’s Research Hospital, Memphis, TN were also reared for the 
present studies. 1) A GFP-transgenic Tg(fli1:EGFP)y1 zebrafish; the endothelial cells of 
this transgenic fish express green fluorescent protein (GFP) and hence, can be visualized 
by fluorescence microscopy (Lawson and Weinstein, 2002). 2) casper, named for its 
ghost-like appearance, lacks all melanocytes and iridiophores and thus, the body is almost 
entirely transparent (White et al., 2008). The casper fish was generated from the nacre 
mutant that lacks melanocytes due to mutation in the gene encoding the mitfa gene (Lister 
et al., 1999) and the roy orbison (roy) zebrafish, which is a spontaneous mutant and lacks 
iridophores (White et al., 2008).  In adult female casper zebrafish, individual follicles can 
be easily observed. Maintenance and breeding of both the Tg(fli1:EGFP)y1 and casper 
zebrafish were carried out as described for wild-type zebrafish above.  
 
Intraperitoneal Injection 
 Adult female zebrafish in spawning condition were anesthetized with 0.04% 
tricaine methanesulfonate (0.1 mg in 250 ml) in egg water (reverse osmosis purified 
water containing 3 drops 1% methylene blue per 4L) and weighed. The fish were 
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positioned in a custom-made device consisting of a plastic dropper cut lengthwise and 
attached to a microscope slide with cyanoacrylic adhesive (superglue). This slide was 
then placed in the bottom of a 100mm Petri dish filled with saline. A syringe filled with 
the injectate was fitted with a 30 gauge needle and the assembly was placed in a 
micromanipulator. With the aid of a dissecting microscope, the needle was inserted into 
the IP cavity of the anesthetized zebrafish. The chemical was then injected intraperitoneal 
cavity, dental adhesive powder was placed over the injection site as a wound dressing, 
and the fish was allowed to recover from anesthesia and returned to its tank.  
 Markers that were injected into the zebrafish are described below. The fluorescent 
marker, trypan blue (Sigma Aldrich, St. Louis, MO) (0.2 grams) was dissolved in 20 ml 
Cortland’s fish saline (Wolf, 1969) containing 29 gram NaCl, 0.92 gram CaCl2, 1.52 
gram KCl2, and 0.92 gram MgSO4, pH 7.4 adjusted with HCl and NaHCO3. The 1% 
solution (1gm TB dissolved in 100ml Cortland’s saline) was transferred to a dialysis tube 
and dialyzed overnight against Cortland’s saline to remove small impurities. Prior to 
injecting TB into zebrafish, the 1% stock solution of TB in some experiments was diluted 
1:1 (0.5%) or 1:4 (0.25%) with Cortland’s saline.  
 Other fluorescent markers used include FITC-lectin (0.1 mg/ml) from EY Labs 
(San Mateo, CA), FITC-casein (0.5 mg/ml) from Anaspec Inc. (Freemont, CA), and 
mCherry (1 mg/ml) from BioVision Inc (Milpitas, CA). These markers were also 










 To visualize zebrafish ovaries, the fluorescent-marker-treated zebrafish were 
anesthetized in tricaine methanesulfonate and sacrificed by decapitation. The ovaries 
were removed and placed on a glass depression slide filled with Cortland’s saline.  
 Brightfield microscopy: Slides were placed on a Nikon upright microscope 
(Eclipse E400) trans-illuminated by a halogen lamp and viewed with either a 4x air 
objective (NA 0.13) or a 10x objective (NA 0.25). Images were captured using a Canon 
digital camera attached to the camera port of the microscope.  
 Fluorescence microscopy: For fluorescence visualization of zebrafish ovary, the 
epi-illumination setup on the Nikon microscope was used, which included a mercury 
lamp and interchangeable UV, blue and green interference filter sets. This allowed 
excitation of the ovaries in slides with either UV (wavelength about 350 nm), blue 
(wavelength about 485 nm) or green (wavelength about 540 nm) light. The blue, green or 
red emission, respectively, was viewed using either the 4 or 10X air objective and the 
images captured with a Canon digital camera.  
 The excitation and emission filter sets used for the various fluorescent markers are 
noted below.  
 Fluorescent marker excitation filter set emission filter set 
 Trypan blue    green   red  
 FITC-lectin   blue   green  
 FITC-casein   blue   green  
 mCherry   green   red  
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 As GFP has a major excitation peak at 488 nm and peak emission at 509 nm 
(Heim et al., 1995), the blue excitation interference filter set and green emission filer set 
were used to visualize and image ovaries dissected from Tg(fli1:EGFP)y1 zebrafish. 
 
 Estimating Protein-Trypan Blue Binding 
 An in vitro assay was performed to determine TB binding to proteins. Different 
concentrations of TB were mixed in a 96-well plate with different concentrations of 
bovine serum albumin (BSA). Then, the plate was epiilluminated with the green 
excitation filter set of a fluorescence microscope and observed with a 4x objective. A 
Canon camera was used to capture the emitted fluorescence and the same exposure 
setting was used for all the wells. The fluorescence intensity in each well was determined 
using ImageJ and the results were plotted. 
 
Analysis Methods 
 The brightfield and fluorescence digital images from the Canon digital camera 
were downloaded into a computer as .jpg files. These image files were analyzed using 
ImageJ image analysis software (http://rsb.info.nih.gov/ij/). To quantify distances, an 
image of a stage micrometer was captured and used to calibrate length in ImageJ. 
Fluorescence digital images were split into red, blue and green channels in ImageJ. It is 
possible that fluorescence emission in a specific channel is contaminated by emission in 
other channels. Hence, separating the channels and using only the color channel specific 







Ovarian Follicle Diameter Measurement 
 Ovarian follicular diameter was determined from brightfield images. In these 
images, ovarian follicles that were in sharp focus were selected. At the maximum 
diameter location, a line was drawn across the ovarian follicle using a calibrated Line 
Tool in ImageJ. The length of the line was then calculated from ImageJ and recorded in 
Microsoft Excel as the diameter of the ovarian follicle. 
 
Ovarian Follicle Fluorescence Intensity Measurement 
 The fluorescence intensity within ovarian follicles was determined from the 
respective channel of the fluorescence image. Fluorescence intensity of TB in ovarian 
follicles was determined using the red channel after splitting the fluorescence image as 
described above. A line was drawn across an oocyte at midline with the calibrated line 
tool in ImageJ. The average fluorescence intensity along that line was recorded in 
Microsoft excel from ImageJ as the mean fluorescence intensity of that ovarian follicle. 
For FITC-lectin and FITC-casein, the green channel was used, while for mCherry the red 
channel was used. 
 
Quantifying Ovarian Follicular GFP Fluorescence 
 To determine the percentage of GFP in ovarian follicles dissected from 
Tg(fli1:EGFP)y1 transgenic zebrafish, the green channel of the split fluorescence image 
was used. The GFP signal threshold was adjusted after background subtraction and a 
calibrated Circle tool from ImageJ was used to draw a circle within the vascularized 
region of a follicle-enclosed oocyte. The fluorescence intensity within this circular region 
was recorded in Microsoft Excel from ImageJ as the mean percent of thresholded GFP 
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fluorescence per unit calibrated area within the vascularized region of that ovarian 
follicle.  
 
Ovarian Follicle Blood Vessel Diameter Measurement 
 The green channel of the split fluorescence image was used to determine the 
diameter of blood vessels on ovarian follicles dissected from Tg(fli1:EGFP)y1 transgenic 
zebrafish,. The brightness and contrast of the image was adjusted to optimized levels and 
a vessel that was in sharp focus was selected. Using the calibrated Line Tool of ImageJ, a 
line was drawn along the cross-section of the vessel. The length of the line was recorded 
in Microsoft Excel from ImageJ as the diameter of the blood vessel. This process was 
repeated at about 20 sites along the vessel length and the mean diameter for the vessel 
was calculated. 
 
Exogenous Hormone Treatment 
 Zebrafish were treated with exogenous hormones to determine the effect of 
hormone treatment on ovarian follicle development. The appropriate agent was added to 
the spawning tank containing the female zebrafish to be studied. After 2 days, TB was 
injected intraperitoneally, as described above. Following incubation of different 
durations, the zebrafish were removed, the ovaries were dissected and the various 
measurements made as described above.  
 In this study, the effect of exogenous estradiol and tamoxifen were studied. These 
hormones were purchased from Sigma Aldrich.  Estradiol was added to the spawning 
tank at 1 µg/L and10 µg/L, while tamoxifen was added to the spawning tank at 
concentrations, 5 µg/L and 50 µg/L. 
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In vitro Drug Treatment of Ovarian Follicles 
 The effect of in vitro treatment of drugs on ovarian follicle blood vessel diameter 
were determined in ovarian follicles dissected from zebrafish as described above. The 
ovarian follicles were placed under a microscope and imaged as described above. The 
desired drug was administered and images of the ovarian follicle were taken both before 
and after administering the drug. The images were then analyzed as described above. 
 In this study, the effect of in vitro treatment of ovarian follicles with estradiol, 
epinephrine, histamine and acetylcholine was studied. These hormones were purchased 
from Sigma Aldrich and used at the following concentrations; estradiol (37 µg/ml), 
epinephrine (183.2 µg/ml), histamine (13.3 mg/ml ) and acetylcholine (66 µg/ml).  
 
Statistical Analysis 
 Relationships between follicle diameter and TB fluorescence intensity as well as 
follicle diameter versus blood vessel diameter were analyzed by regression lines and by 
computing Pearson r coefficients. ANOVA was used to analyze blood vessel diameter 







1. Time course of vitellogenin uptake in follicle-enclosed oocytes 
Trypan blue (TB) uptake in wildtype zebrafish as a function of ovarian follicle diameter 
(size class) 
 Wildtype zebrafish injected with TB were sacrificed at 1, 24, 48, and 96 hour 
post-injection. The ovary was then removed, and both bright-field and fluorescence 
images of follicle-enclosed oocytes were taken, as shown for a representative follicle-
enclosed oocyte in Fig. 4. From these images, the diameter and TB fluorescence intensity 
of the follicle-enclosed oocytes were determined as described in Materials and Methods. 
 To determine background fluorescence in follicle-enclosed oocytes, bright-field 
and fluorescence images were obtained using wildtype zebrafish that did not receive any 
TB injection (Fig. 5A). From the images in this Figure, it can be seen that background 
fluorescence was low. Background fluorescence plotted as a function of oocyte diameter 
showed that the fluorescence was low across all size classes of follicle-enclosed oocytes 
(Fig. 5B).  
 In wildtype zebrafish injected with TB and sacrificed at 1 hour post-injection, the 
fluorescence of TB was detectable in follicle-enclosed oocytes (Fig. 6A). However, the 
TB fluorescence was higher than background only in a small number of follicle-enclosed 
oocytes. Also, the fluorescence remained low across all size classes of follicle-enclosed 
oocytes and did not vary as a function of their diameter (Fig. 6B). 
 In follicle-enclosed oocytes dissected 24 hours after TB injection, the TB 
fluorescence was seen in a larger number of oocytes than compared to those dissected at 
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1 hour (Fig. 7A). However, the fluorescence increase was small and limited to a small 
size class of oocytes. The fluorescence also did not vary much as a function of follicle-
enclosed oocyte diameter (Fig. 7B). 
 In contrast, in follicle-enclosed oocytes examined 48 hours after TB injection, the 
TB fluorescence was prominent and visible in a larger number of oocytes (Fig. 8A). This 
higher fluorescence was seen over a wider range of oocyte diameters. Also, the 
fluorescence increase with diameter was high (r = 0.75) (Fig. 8B). Most of the follicle-
enclosed oocytes that exhibited high fluorescence were in the 300-500 micron diameter 
range.  At 96 hours post TB injection, the fluorescence decreases overall and this 
decrease is seen for follicle-enclosed oocytes of all diameters (Fig. 9). 
 
TB uptake in Tg(fli1:EGFP)y1 zebrafish 
 As similar to wildtype zebrafish, the background fluorescence was very low in 
ovarian follicles dissected from Tg(fli1:EGFP)y1 zebrafish not administered any TB (Fig. 
10). At 24 hours post injection, the TB fluorescence was higher than background and 
similar across various follicle-enclosed oocyte diameters (Fig. 11). In this and other 
similar experiments, data from fish treated similarly were pooled together as variations in 
responses among fish were small. However, at 48 hours post injection TB fluorescence 
was high and approached saturation in several oocytes (Fig. 12). The highest fluorescence 
was mainly evident in follicle-enclosed oocytes in the diameter range of 300-500 microns 
(Fig. 12). Also, the increase in fluorescence with oocyte diameter was steep (r=0.76), 




 In follicle-enclosed oocytes examined 96 hours after TB injection, fluorescence in 
all follicles declined as compared to that in oocytes examined 48 hours post injection 
(Fig. 13). Moreover, the highest fluorescence was also lower. This result suggested that 
the highest TB fluorescence was evident in follicle-enclosed oocytes examined at 48 
hours after TB injection. 
 In addition, TB fluorescence was determined in follicle-enclosed oocytes 8 and 14 
days after injection in Tg(fli1:EGFP)y1 zebrafish. At both these time points the 
fluorescence in ovarian follicles had declined further (Figs. 14 and 15). By 14-days, the 
fluorescence was close to background levels.  
 
Trypan Blue Binding to Proteins 
 Injection of TB into the peritoneal cavity of zebrafish resulted in an increase in 
fluorescence in the follicle-enclosed oocytes. An in vitro assay of TB-bovine serum 
albumin binding was performed to determine if the fluorescence increase was due to 
native unbound TB or protein-bound TB. Changes in TB fluorescence as a function of 
albumin concentration were plotted for various TB concentrations (Fig. 16). From the 
plot is can be seen that when no TB is present, no fluorescence was evident at all BSA 
concentrations indicating that albumin had no native fluorescence. Similarly, when no 
albumin was present in the solution, the trypan fluorescence was low and similar to 
background at all TB concentrations indicating that TB does not fluoresce in the absence 
of BSA.  However, in the presence of TB in the solution, the fluorescence increases 






 Uptake characteristics of other fluorescent probes  
 In wildtype zebrafish injected individually with FITC-casein, FITC-lectin, and 
mCherry, no fluorescence emission was detectable in the follicle-enclosed oocytes for all 
three probes (Figs. 17A, B). 
 
2. Blood vessel diameter - ovarian follicle diameter relationship 
 To determine if ovarian blood vessels can be visualized using GFP fluorescence, 
follicle-enclosed oocytes dissected from Tg(fli1:EGFP)y1 zebrafish were visualized by 
confocal microscopy. Blood vessels of Tg(fli1:EGFP)y1 zebrafish express EGFP and so 
the vessels can be visualized using GFP fluorescence. Images in (Fig. 18A) show that 
GFP fluorescence in ovarian blood vessels was detectable.  
 Using GFP fluorescence images obtained using fluorescence microscopes 
together with brightfield images of the follicle-enclosed oocytes indicated that blood 
vessel diameter increased together with oocyte diameter (Fig. 18B). However, this 
relationship was not directly proportional suggesting that follicle-enclosed oocytes with 
similar size classes had blood vessels with a wide-range of diameters. Also, the 
percentage of GFP fluorescence measured per unit area within the vascularized region of 
ovarian follicles extracted from Tg(fli1:EGFP)y1 zebrafish did not vary as a function of 
ovarian diameter (Fig. 19).  
 While the majority of follicle blood vessels were thought to be in the capillary 
size class and thus without significant smooth muscle investments, increasing evidence in 
other systems suggests that myoepithelial pericytes may affect capillary diameter in some 
cases (Schonfelder et al., 1998). Thus, control experiments were done to determine 
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whether this variation in blood vessel diameter was due to true growth of endothelium or 
to short-term action of hormones and neurotransmitters on contractile elements.  
Effect of histamine treatment on ovarian follicle blood vessel diameter  
 The effect of histamine, which dilates blood vessels by acting on vascular smooth 
muscle cells and pericytes (Wahl and Kuschinsky, 1979), was determined by applying the 
drug (30 µl of 13.3 mg/ml) in vitro on follicle-enclosed oocytes dissected from  
Tg(fli1:EGFP)y1 zebrafish. Vessel diameter quantified from images captured one per 
minute did not change significantly in response to histamine treatment (Fig. 20). 
 
Effect of acetylcholine treatment on ovarian follicle blood vessel diameter  
 Acetylcholine induces dilation of blood vessels by acting on muscarinic receptors 
on endothelial cells leading to relaxation of the vascular smooth muscles (Furchgott and 
Zawadzki, 1980). Acetylcholine (1.66 µg at 66 µg/ml) did not significantly change blood 
vessel diameter of follicle-enclosed oocytes dissected from Tg(fli1:EGFP)y1 zebrafish 
(Fig. 21). No changes were also evident when acetylcholine concentration was raised to 
10 mM.  
 
Effect of epinephrine treatment on ovarian follicle blood vessel diameter  
 Epinephrine induces diameter changes of blood vessels by acting on adrenergic 
receptors on smooth muscle cells (Gillespie and Hamilton, 1966). Epinephrine (183.2 
ug/ml) did not cause any significant changes in blood vessel diameter on follicle-enclosed 







Effect of estradiol treatment on ovarian follicle blood vessel diameter  
 While it is known that estradiol is important in ovarian development and 
maturation, information on the effect of estradiol on blood vessels in zebrafish ovarian 
follicles is not available. However, in other systems, estradiol may act on nitric oxide 
pathways to affect blood vessel diameter (Lang et al., 1997; McNeill et al., 2002). 
Estradiol (37 µg/ml) did not significantly change ovarian blood vessel morphology in 
follicle enclosed oocytes from Tg(fli1:EGFP)y1 zebrafish (Fig. 23). The lack of a 
response persisted for more than 40 minutes after estradiol treatment. 
 
3. Effect of hormone treatment on ovarian development 
Estradiol treatment 
 Estradiol is an important hormone involved in ovarian development and 
maturation. Hence, to determine whether addition of exogenous estradiol changes ovarian 
development and maturation, the hormone (10 µg/L) was added to fish tanks containing 
Tg(fli1:EGFP)y1 zebrafish and the fish injected with TB one day later. But within three 
days of adding estradiol, all five the treated fish died. The cause of death may be the 
combined effects of high estradiol levels and TB injection. 
 
Tamoxifen treatment 
 The effect of tamoxifen, a competitive antagonist of estradiol, on zebrafish 
development was determined by treating Tg(fli1:EGFP)y1 zebrafish with the agent and 
then injecting TB one day later. In fish treated with a low dose of tamoxifen (5 µg/L) and 
injected with TB, ovaries dissected at 48 hours after injection were stained blue (Fig. 24). 
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However, these ovaries appeared similar to those dissected from tamoxifen treated 
zebrafish, but not injected with TB (Fig. 25). In response to tamoxifen treatment, the GFP 
fluorescence in ovarian follicles deteriorated (Figs. 24 and 25). The deterioration was 
similar in both TB-injected and TB-free fish, suggesting that TB injection may not have 
been the reason for the lack of GFP fluorescence in ovarian follicles.  
 At a higher dose of tamoxifen (50 µg/L), ovaries of the treated Tg(fli1:EGFP)y1 
zebrafish appeared to be cytolysing and contained only a few small blue follicle-enclosed 
oocytes (Fig. 26). Further, the big follicles appeared to be detached and lying free within 
the lumen. Also, the ovaries appeared deteriorated and disintegrating with many dead and 
cytolyzing ovarian follicles evident. In addition, the TB fluorescence was low (Fig. 26). 
 In addition, to determine the long term effects of low dose tamoxifen (5 µg/L), 
ovaries of tamoxifen-treated Tg(fli1:EGFP)y1 zebrafish, were examined at 72 hours, 96 
hours, and 8 days after treatment (Fig. 27). At 72 hours post-treatment the ovarian 
integrity was poor and the ovaries appeared deteriorated. The large follicles appeared 
detached and lying loose within the lumen. At 96 hours post treatment, detached follicles 
similar to that seen at 72 hours were evident. In addition, resorption of ovarian follicles 
was pronounced; resorbing follicles were collapsed with irregular outlines and were no 
longer spherical. A similar resorption of ovarian follicles was also seen in ovaries 
dissected 8-days after tamoxifen treatment. At all time points, the morphology of blood 
vessels appeared distorted. 
 
Changes in ovarian follicle growth and development in casper transgenic zebrafish  
 The casper transgenic zebrafish is mostly transparent and hence, ovaries are 
visible inside the zebrafish. This eliminated the need to sacrifice females to dissect 
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ovaries to study their growth and development. Importantly, casper fish also allowed 
longitudinal study of ovarian changes with time in vivo. Ovarian follicles in the same 
casper zebrafish were imaged for more than 7 weeks at regular intervals. A montage of 
the images show development of ovarian follicles over time (Fig. 28). The developmental 
phase is followed by a regression phase during which the ovarian follicles do not develop 
but regress. After several days in the regression phase, the development phase restarts. 
Diameters of follicle-enclosed oocytes calculated from brightfield images, show cyclic 
diameter changes over a 30-day period (Fig. 29). Thus, the casper images suggest that 
zebrafish ovarian follicles cycle naturally through development and regression periods   
 To determine the effect of tamoxifen on ovarian follicles using casper transgenic 
zebrafish, we treated one fish with a low dose (5 µg/L) tamoxifen and another with a high 
dose (50 µg/L) of tamoxifen. Examination of the ovaries after 7 days showed that the 
ovaries had regressed in both fish (Fig. 30). In a control casper zebrafish not treated with 
tamoxifen, some regression was also seen (Figs. 28, 29 and 30). However, the ovarian 
follicles of the tamoxifen-treated fish did not cycle back to the development phase and 
remained regressed. The control casper zebrafish ovaries cycled back to the development 
phase as shown in Figures 28 and 29.  
 To further test if the tamoxifen effect on ovarian follicle regression was 
permanent, casper zebrafish that were being treated with tamoxifen were removed and 
placed in a tank without tamoxifen. Seven days after placing the fish in tamoxifen-free 
tank, the ovarian follicles again began to develop, grow and fill with opaque yolk (Fig. 
31). This suggested that the effect of tamoxifen was not permanent. 
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 While estradiol in vivo promotes ovarian growth and development in zebrafish, it 
is not clear if estradiol in vitro has similar effects. To determine this, casper zebrafish 
were placed in a tank containing estradiol (10 µg/L). However, as seen with 
Tg(fli1:EGFP)y1 zebrafish, the casper zebrafish all died in a few days. Hence, the 
concentration was lowered to 1 µg/L and the experiment repeated. In casper zebrafish 
with gravid ovaries filled with large follicle-enclosed oocytes, seven days after estradiol 
treatment the oocytes began to regress (Fig. 32) and remained in the regressed state as 
long as estradiol was present in the tank. If the estradiol treatment was initiated when the 
casper zebrafish follicle-enclosed oocytes were in a natural regressed state, then the 
follicles remained in the regressed state (Fig. 33).  
 After maintaining the fish in the estradiol-containing tank for two weeks, they 
were transferred to an estradiol-free tank. Soon after this transfer, the ovarian follicles 
began to recover and develop, as similar to post-tamoxifen treatment, suggesting that the 
effect of estradiol was not permanent (Fig. 34). 
 In additional experiments, the longer term exposure to exogenous estradiol was 
explored. Observations in live female casper zebrafish placed in an estradiol-containing 
tank for more than four weeks revealed regression of ovarian follicle development, as 
seen for shorter term estradiol treatment. In addition, white structures similar to that of 
zebrafish testis began to develop (Fig. 35). This gave the appearance that long-term 
estradiol treatment led to development of male sex organs in female zebrafish. To check 
if this was a real change, control male Tg(fli1:EGFP)y1 zebrafish were sacrificed and the 
authentic testis dissected. Images of testis showed the presence of seminiferous tubules 
with interspersed lipid (Fig. 36). Similarly, the estradiol-treated female zebrafish were 
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sacrificed and the novel white tubular structure and the ovaries were dissected. The novel 
white structure consisted of adipose tissue with clear lipid droplet inclusions. Images of 
the ovaries revealed that there was severe regression of the ovarian follicles, with only 
previtellogenic follicles detectable in the ovary (Fig. 37). Further, the gaps in the ovary 
were filled with increasing amounts of adipose tissue (Fig. 37). In the intact fish, the 
adipose tissue appeared to look like testis of male zebrafish (Fig. 35). Therefore, long 
term estradiol treatment led to the regression of ovarian follicle development with 
adipose tissue filling the gaps formed due to regression.   
 In additional experiments, casper transgenic zebrafish were injected (10% 
injectate volume/body weight) with TB either at low (0.25% TB) or high dose (0.5% TB) 
in order to follow the development of ovarian follicles via TB uptake in live zebrafish. 
However, imaging the TB through the body wall was difficult and high background 
obscured imaging the fluorescence of ovarian follicles, This was especially true when 






 In the current set of studies, wildtype, Tg(fli1:EGFP)y1, and casper zebrafish 
were utilized to determine the time course of development of follicle-enclosed oocytes. 
The main findings from these studies are, (1) uptake of TB into zebrafish follicle-
enclosed oocytes in vivo was maximum at 48 hours post-treatment, (2) development of 
follicle blood vessels closely followed development of follicle-enclosed oocytes, and (3) 
treatment of zebrafish with exogenous estradiol or its antagonist, suppressed follicular 
development during the treatment period.    
 
Evidence in support of trypan blue as a vitellogenin endocytosis probe 
 In the present experiments, TB was used as a fluorescent marker for oocyte 
growth and development. TB has been used extensively for decades as a marker for cell 
viability (Hathaway et al., 1964; Pachman et al., 1971; Ward and Becker, 1967). Thus, 
TB exclusion assay is a standard way to distinguish between healthy, and damaged or 
dead cells. Paradoxically, TB incorporates into vertebrate oocytes as previously reported 
(Anderson and Telfer, 1970; Callebaut et al., 1981; Selman and Wallace, 1983). These 
studies also suggest that incorporation of TB into living oocytes is linked to oocyte 
uptake of vitellogenin and the inclusion of TB into oocytes does not simply imply 
damaged or dead oocytes. This conclusion is supported by preliminary experiments that 
show injection of TB into gravid female zebrafish, results in oviposition of TB-
containing eggs which when fertilized, develop into healthy embryos. Importantly, in the 
embryos, TB is localized to the yolk cell and excluded from the embryonic cells (Fig. 
38). This localization continues into the larval stage (Fig. 39).  
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 Confocal images of the embryos indicate the typical red fluorescence only in the 
yolk globules (Figs. 40, 41) and not in the ooplasm of the oocyte. These results support 
the hypothesis that TB incorporation is primarily coupled with vitellogenin uptake in 
oocytes and the TB appears to colocalize with the processed vitellogenin (i.e. lipovitellin 
and phosvitin) in membrane enclosed yolk vesicles. Further, these experiments also show 
that TB uptake itself does not limit oocyte growth or embryonic development and thus is 
non-toxic to the animal and its cells.  
 Thus, broadly it appears that TB has contrasting functions. The marker the reports 
extent of cell damage and death in one assay, while it reports growth and development in 
another assay. This difference could be explained via the duration for which the two 
assays are performed. For TB exclusion assay, the typical incubation time of the cells 
with the marker is 15 minutes or less (Hathaway et al., 1964; Pachman et al., 1971; Ward 
and Becker, 1967). Accordingly, in the present studies no TB fluorescence was evident in 
oocytes dissected at 1 hour post TB injection. This clearly suggests that the oocytes were 
not damaged or dead and the intact living cell excluded short-term TB uptake. In contrast, 
TB fluorescence was high in oocytes dissected after several hours or days post injection. 
Thus, over longer durations in the hours or days range, TB likely works as a marker of 
protein uptake via receptor-mediated endocytosis, as evidenced by its specific 
localization in vitellogenic membrane-bound yolk vesicles. Thus, the contrasting results 
obtained with TB depends on whether its presence inside cells is detected within minutes, 






Trypan blue uptake into follicle-enclosed oocytes 
 In both wild-type and Tg(fli1:EGFP)y1 zebrafish, intraperitoneal injection of TB 
resulted in a maximum increase in fluorescence in follicle-enclosed oocytes at 48 hours 
post injection. Both at earlier and later time points, the fluorescence in follicle-enclosed 
oocytes was less than at 48 hours. Thus, measurements made before 48 hours showed that 
the fluorescence increased gradually with time, while those made after 48 hours showed 
that the fluorescence declined gradually with time post injection. Therefore, taken over 
the entire duration, the data suggest that injection of TB led to a gradual increase in 
follicle-enclosed oocyte fluorescence that peaked at 48 hours, followed by a decline.    
 The increase in fluorescence in follicle-enclosed oocytes following TB injection 
suggests uptake of TB into the oocytes. TB has been used extensively as a marker for 
oocyte development in several other vertebrates (Callebaut et al., 1981; Gutzeit and 
Arendt, 1994; Harrisson et al., 1981; Isayeva et al., 2004; Selman and Wallace, 1983; 
Wajc et al., 1977). Exposing live ovarian follicles to TB causes its incorporation into 
oocytes (Anderson and Telfer, 1970; Danilchik and Denegre, 1991). Using Japanese 
quail, it was shown that even at low concentrations, TB is taken up into oocytes 
(Harrisson et al., 1981). Further, the same study also showed that TB fluorescence in 
oocytes is concentration dependent (Harrisson et al., 1981). The in vitro assay in the 
present study also showed that TB fluorescence increases with concentration. Also, TB 
fluorescence was detectable only when the marker was bound to a protein and increased 
with increasing protein concentration. Therefore, high TB fluorescence in follicle-
enclosed oocytes suggests high incorporation of TB and its high association with yolk 
proteins in the oocyte.  
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 Thus, the time-dependent increase in TB fluorescence up to 48 hours suggests a 
time-dependent increase in TB incorporation into the follicle-enclosed oocytes. TB 
incorporation in oocytes of other vertebrates is linked to uptake of the yolk protein, 
vitellogenin into the oocytes (Anderson and Telfer, 1970; Callebaut et al., 1981; Gutzeit 
and Arendt, 1994; Selman and Wallace, 1983). Therefore, an increase in vitellogenin 
accumulation can lead to increase in TB accumulation, and increased TB fluorescence. 
During development of follicle-enclosed oocytes, vitellogenin accumulation and increase 
in oocyte size is highest during stage 3 (Clelland and Peng, 2009; Lessman, 1999, 2009; 
Lubzens et al., 2010; Matsuda et al., 2011; Selman and Wallace, 1983). The results in this 
study show that TB fluorescence was highest in 300-500 micron diameter oocytes. 
Oocytes in this diameter range are likely to be in stage 3 in teleost fish (Lessman, 1999, 
2009; Selman and Wallace, 1983). Hence in the present study, it is likely that follicle-
enclosed oocytes with high TB fluorescence were in the vitellogenic phase. So it follows 
that the gradual increase in TB fluorescence is a direct indication of the gradual 
development of vitellogenin accumulation in follicle-enclosed oocytes. In other words, 
the time line of changes in TB fluorescence in follicle-enclosed oocytes provide a new 
method to establish the time line of development of these oocytes. Thus, the current 
studies suggest that vitellogenin uptake reaches a maximum in oocytes presumably at 48 
hours after introduction via injection ip.  These time-line data match findings reported in 
a recent publication showing uptake of FITC-labeled goldfish vitellogenin into zebrafish 
ovarian follicles (Matsuda et al., 2011). The similar TB uptake characteristics in both 
wild-type and Tg(fli1:EGFP)y1 zebrafish indicate that ovarian development in transgenic 
zebrafish was similar to that in the wildtype zebrafish. Hence, other ovarian development 
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data obtained using Tg(fli1:EGFP)y1 zebrafish in the present set of studies should be 
representative for zebrafish in general. 
 In addition, the TB fluorescence was also lower in follicle-enclosed oocytes 
dissected at time points after 48 hours. The cause for this decline is not clear. It may be 
that TB dissociates from vitellogenin, during the enzymatic processing of vitellogenin in 
the endo-lysosome vesicles. The gradual decline in fluorescence may be due to the 
gradual breakdown of vitellogenin by enzymatic processing. In addition, with increasing 
time, vitellogenin may migrate deeper into follicle-enclosed oocytes as it is processed 
into lipovitellin and phosvitin and stored in membrane-bound yolk vesicles. Hence, TB 
associated with vitellogenin also moves to those deeper layers as vesicle trafficking 
occurs. Thus, the excitation light and emission fluorescence must travel longer distances 
through the yolk-filled ooplasm and hence, the TB fluorescence at the surface of follicle-
enclosed oocytes may appear low. Additional studies are needed to further determine 
which of the above two possibilities contribute to the decline in TB fluorescence at time 
points beyond 48 hours after TB injection.  
 While TB injection into zebrafish caused an increase in fluorescence in follicle-
enclosed oocytes, FITC-casein, FITC-lectin, and mCherry injection did not cause any 
change in fluorescence. These results suggest that only TB was taken up into oocytes, and 
the other markers were not. In previous studies, TB was present between the follicular 
epithelial cells, suggesting that the dye moves through the various layers of the ovarian 
follicle via a similar path used by vitellogenin (Anderson and Telfer, 1970). The exact 
reason for non-uptake of the other markers needs additional studies, but endocytotic 
receptor specificity is a likely factor.   
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Blood vessel diameter response to exogenous agents 
 Since blood vessels of Tg(fli1:EGFP)y1 zebrafish exhibit GFP fluorescence, 
vessel morphology and diameter were detectable using epifluorescence microscopy. 
These data showed a possible association of larger blood vessels with larger ovarian 
follicles. However, ovarian follicles of similar diameter had blood vessels over a wide 
diameter range. No association was detectable between the percentage of GFP 
fluorescence in the blood vessels and ovarian diameter. Overall, these data point to non-
uniformity in blood vessel diameter in ovarian follicles. 
 The differences in blood vessel diameter may be due to blood vessel growth. 
Angiogenesis involves growth of new blood vessels. In other species, ovarian 
angiogenesis has been studied extensively and reviewed (Fraser, 2006; Leali et al., 2012; 
Plendl, 2000; Reynolds et al., 2002). Addition of endogenous endothelial cells to newly 
forming blood vessels causes changes in diameter. Hence, it is possible that the 
variability in blood vessel diameter in Tg(fli1:EGFP)y1 zebrafish ovarian follicles may 
be due to angiogenesis. 
 Another possibility for the variation in blood vessel diameter may be the action of 
agents that act locally on blood vessels and induce vessel contraction or dilation. Agents 
such as histamine, acetylcholine, epinephrine, and estradiol induce diameter changes in 
blood vessels (Furchgott and Zawadzki, 1980; Gillespie and Hamilton, 1966; Lang et al., 
1997; Ross and Klebanoff, 1967; Wahl and Kuschinsky, 1979). However, they act on 
smooth muscle cells of the blood vessels to induce changes in diameter. The images 
captured from Tg(fli1:EGFP)y1 zebrafish show that ovarian blood vessel diameters are in 
the 5-15 micron range. The small diameters of the blood vessels suggest that they may be 
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capillaries. Capillaries do not have surrounding smooth muscle cells, but are associated 
with smooth muscle like cells called pericytes (Bruns and Palade, 1968; Murakami et al., 
1979; Tsukada et al., 1996) that may be involved in modifying capillary diameters 
(Kawamura et al., 2004; Reynolds et al., 2000; Schonfelder et al., 1998).   
 Addition of any of the four blood vessel dimension modifying agents to follicle-
enclosed oocytes dissected from Tg(fli1:EGFP)y1 zebrafish did not cause any significant 
change in ovarian blood vessel diameter. Hence, it can be concluded that differences in 
blood vessel diameter in ovarian follicles of various diameters are not likely due to the 
short term effect of the hormones and neurotransmitters on the contractile elements. The 
observed changes in diameter are likely associated with the growth of blood vessels 
together with the growth of ovarian follicles. Additional studies are required to confirm 
this interpretation. 
 
Effect of exogenous hormones on development of follicle-enclosed oocytes  
 Estradiol plays a major role in oocyte development and maturation. In this study, 
the effect of exogenous estradiol and its antagonist, tamoxifen, on follicle-enclosed 
oocyte growth and development were determined. The experiments were done using both 
Tg(fli1:EGFP)y1 and casper zebrafish. The results showed that because the development 
of follicle-enclosed oocytes in casper zebrafish could be directly visualized without the 
need to sacrifice the fish, casper zebrafish can be a highly useful model in ovarian 
development studies. 
  At high doses of 10 g/L, exogenous estradiol led to death of Tg(fli1:EGFP)y1 
zebrafish. The reasons for this response were not entirely clear. However, exogenous 
estradiol reportedly can increase vitellogenin synthesis, extravascular edema and kidney 
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failure (van der Ven et al., 2007). These may have been the cause for the death of the 
zebrafish in the present study and need further testing. At a lower dose of exogenous 
estrogen (i.e. 1 g/L) all the zebrafish survived. It is possible that at this low dose, the 
harmful side-effects of estradiol treatment on the kidney and blood vessels may have 
been less severe allowing survival. Hence, further experiments to determine changes in 
ovarian follicles were done at 1g/L estradiol 17. 
 At the lower exogenous dose of 1g/L, estradiol led to the regression in ovarian 
development and this regression was maintained for the duration of the estradiol 
treatment. This interpretation is supported by the smaller size of the follicle-enclosed 
oocytes in casper zebrafish. Production of endogenous estradiol is under the control of 
follicle-stimulating hormone generated by the pituitary. Follicle-stimulating hormone acts 
on theca cells of the ovary to induce estrogen production (Clelland and Peng, 2009; 
Lubzens et al., 2010). Hence, addition of exogenous estradiol may act in a feedback 
manner to shutdown follicle-stimulating hormone production. This could then lead to 
lower endogenous production of estrogen and hence, stop vitellogenin production and 
development of follicle-enclosed oocytes. However, this pathway needs verified in future 
experiments.  
 Tamoxifen, initially known as a nonsteroidal antiestrogen but now classified as a 
selective estrogen receptor modulator (SERM), is used to treat breast cancer in pre and 
postmenopausal patients (Jordan, 2003). In this study tamoxifen treatment caused a 
regression of ovarian development in zebrafish. This regression is possible because 
tamoxifen competitively inhibits estrogen binding to its receptors. But, tamoxifen 
treatment increases the circulating levels of estrogen (Iino et al., 1991; Jordan, 2003). 
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Therefore, the high estrogen level may act in a feedback mechanism to block luteinizing 
hormone production in the pituitary gland. Luteinizing hormone is involved in ovarian 
maturation (Clelland and Peng, 2009; Lubzens et al., 2010). This may be the reason for 
the sustained lack of ovarian development in response to tamoxifen treatment. Another 
possibility is that tamoxifen may be acting as an agonist as similar to estradiol, leading to 
similar regressive effects on oocyte development.  The higher estradiol produced due to 
tamoxifen treatment may also have increased edema of the ovarian blood vessels and this 
may have caused the blood vessels in images of Tg(fli1:EGFP)y1 zebrafish ovarian 
follicles to appear disorganized.  However, these possibilities need to be tested in future 
experiments. 
 The present experiments also show that reversing the prolonged treatment with 
either estradiol or tamoxifen, leads to reversing of the ovarian development status i.e., the 
effects of exogenous estradiol and tamoxifen were reversible. This reversibility lends 
additional support to the interpretation that estradiol and tamoxifen caused ovarian 
regression by blocking follicle-stimulating hormone and luteinizing hormone production 
in the pituitary rather than by causing damage to the ovarian follicles. Again, this 






 In conclusion, the present sets of experiments provide a time-line of oocyte 
growth, vitellogenin endocytosis, and follicle-enclosed oocyte development in zebrafish 
using an exogenous marker, TB. The results of vascular morphometrics provide some of 
the first data on vascularization of the different size classes of zebrafish follicle-enclosed 
oocytes. The experiments also suggest that exogenous hormones may disrupt the natural 
growth and development cycle of ovarian follicles in zebrafish. Thus, these studies 
provide the foundation, and have developed the tools, for additional studies to define 
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Fig. 1. Stages of oogenesis in zebrafish. Top. Microscopic images of oocytes isolated 
from zebrafish ovaries at different stages of development. Bottom. A schematic 
representation of stages in fish oocyte development (reprinted from Lubzens, E., Young, 
G., Bobe, J., Cerda, J., 2010. Oogenesis in teleosts: how eggs are formed. General and 
comparative endocrinology 165, 367-389. with kind permission from Springer 




Fig. 2. Schematic representation of vitellogenesis and receptor mediated endocytosis 
in oocytes (reprinted with from www.springerimages.com/Images/Chemistry/1-10.10
07_s11665-008-9281-x-5) with kind permission from Springer Science+Business 




Fig. 3. Schematic representation of ovarian wall components (from brook trout). OE 
- ovarian epithelium; TF- theca folliculi; FE - follicle cell epithelium; C - chorion 




Fig. 4. Trypan blue uptake in zebrafish oocytes. Representative fluorescence (top) and 
brightfield (bottom) images show trypan blue uptake into oocytes at 48 hours after TB 
treatment. Note trypan blue stained oocytes appear blue in the brightfield image. 
Arrows show examples of oocyte diameter measurement sites marked using the 






Fig. 5. Background fluorescence in zebrafish ovarian follicles. A: Brightfield (left) 
and fluorescence (right) images of ovarian follicles from fish not subjected to any 
injection. Arrows show examples of oocyte diameter measurement sites marked 
using the calibrated Line Tool in ImageJ. B: Plot at bottom shows fluorescence in 











oocyte diameter vs trypan blue intensity 


























0 200 400 600
A 
B 




Fig. 6. Trypan blue fluorescence at 1 hour post injection. A: Brightfield (left) and 
fluorescence (right) images of ovarian follicles in an ovary examined 1 hour after 
trypan blue injection into the zebrafish. Arrows show examples of oocyte diameter 
measurement sites marked using the calibrated Line Tool in ImageJ. B: Plot at 
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Fig. 7. Trypan blue fluorescence at 24 hour post injection. A: Brightfield (left) and 
fluorescence (right) images of ovarian follicles in an ovary dissected 24 hours after 
trypan blue injection into the zebrafish. Arrows show examples of oocyte diameter 
measurement sites marked using the calibrated Line Tool in ImageJ. B: Plot at 
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Fig. 8. Trypan blue fluorescence at 48 hour post injection. A: Brightfield (left) and 
fluorescence (right) images of ovarian follicles in an ovary dissected 48 hours after 
trypan blue injection into the zebrafish. Arrows show examples of oocyte diameter 
measurement sites marked using the calibrated Line Tool in ImageJ. B: Plot at 
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Fig. 9. Trypan blue fluorescence at 96 hour post injection. A: Brightfield (left) and 
fluorescence (right) images of ovarian follicles in an ovary dissected 4 days after 
trypan blue injection into the zebrafish. Arrows show examples of oocyte diameter 
measurement sites marked using the calibrated Line Tool in ImageJ. B: Plot at 
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Fig. 10. Background fluorescence Tg(fli1:EGFP)y1 zebrafish. Fluorescence in 
ovarian follicles from Tg(fli1:EGFP)y1 zebrafish that were not injected with any 




oocyte diameter vs trypan blue intensity 






































Fig. 11. Fluorescence in Tg(fli1:EGFP)y1 zebrafish ovarian follicles removed 24 
hours after trypan blue injection. Graph shows fluorescence in ovarian follicles as a 
function of their diameter. (n = 3 zebrafish) 









oocyte diameter vs trypan blue intensity 






























Fig. 12. Fluorescence from Tg(fli1:EGFP)y1 zebrafish ovarian follicles 
examined 48 hours after trypan blue injection. Graph shows fluorescence in 
ovarian follicles as a function of their diameter. (n = 2 zebrafish)   
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Fig. 13. Fluorescence from Tg(fli1:EGFP)y1 zebrafish ovarian follicles examined 96 hours 
after trypan blue injection. Graph shows fluorescence in ovarian follicles as a function of 
their diameter. 
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Fig. 14. Fluorescence from Tg(fli1:EGFP)y1 zebrafish ovarian follicles examined 8 
days after trypan blue injection. Graph shows fluorescence in ovarian follicles as a 
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Fig. 15. Fluorescence from Tg(fli1:EGFP)y1 zebrafish ovarian follicles examined 
14 days after trypan blue injection. Graph shows fluorescence in ovarian follicles as 
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Fig. 16. Trypan blue binding to bovine serum albumin. Different concentrations of 
trypan blue were mixed with bovine serum albumin (BSA) in a 96-well plate as in fig. 
13 and the fluorescence of each well was read. The image shows raw fluorescence in 
the wells taken using the rhodamine filter (above dotted line) and FITC filter (below 
dotted line). Note no fluorescence was detectable in the FITC channel. The plot shows 




























Fig. 17. Uptake of other fluorescent probes. A: Top two image sets show oocytes 
dissected from mCherry injected wildtype zebrafish. mCherry fluorescence should be 
visible in the red channel (center). Green channel indicates fluorescence spill over into 
that channel. B: Bottom images show oocytes dissected from FITC-caesein injected 
wildtype zebrafish. FITC-lectin fluorescence should be visible in the green channel 
(far right).  
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Fig. 18. Blood vessel characteristics in Tg(fli1:EGFP)y1 zebrafish ovarian follicles. 
A: Epi-fluorescence images (top) show blood vessels over follicle-enclosed oocytes 
from fli1-GFP zebrafish. B: Graph (bottom) shows ovarian follicle blood vessel 
diameter as a function of the respective ovarian follicle diameter. (n = 4 zebrafish) 
oocyte diameter(microns)
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Fig. 19. GFP fluorescence Tg(fli1:EGFP)y1 zebrafish ovarian follicle blood vessels. 
Graph shows percentage of GFP fluorescence per unit area in ovarian blood vessels 
as a function of oocyte diameter. (n = 2 zebrafish) 
oocyte diameter (microns)
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Fig. 20. Temporal variation in histamine treated Tg(fli1:EGFP)y1 zebrafish ovarian 
follicle blood vessels. A: Images show ovarian follicle blood vessels before, 5, 10 and 
15 min after histamine treatment.  B: Graph shows ovarian follicle blood vessel 
diameter as a function of the time after histamine treatment (p>0.6 compared to 0 
min). 
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Fig. 21. Temporal variation in acetylcholine-treated Tg(fli1:EGFP)y1 zebrafish 
ovarian follicle blood vessels. A: Images show ovarian follicle blood vessels before, 5, 
10, and 15 min after acetylcholine treatment. B: Graph shows ovarian follicle blood 
vessel diameter as a function of time after acetylcholine treatment (p>0.5 compared to 
0 min) 
5 min 0 min
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Fig. 22. Temporal variation in epinephrine-treated Tg(fli1:EGFP)y1 zebrafish ovarian 
follicle blood vessels. A: Images show ovarian follicle blood vessels before, 5, 10, 15 
and 25 min after epinephrine treatment.  B: Graph shows ovarian follicle blood vessel 
diameter as a function of the time after epinephrine treatment (p<0.01). 
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Fig. 23. Temporal variation in estradiol-treated Tg(fli1:EGFP)y1 zebrafish ovarian 
follicle blood vessels. A: Images show ovarian follicle blood vessels before, 10, 15 
and 40 min after estradiol treatment.  B: Graph shows ovarian follicle blood vessel 
diameter as a function of the time after estradiol treatment (p>0.3 compared to 0 min).
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Fig. 24. Effect of Tamoxifen (low dose) treatment on Tg(fli1:EGFP)y1 zebrafish 
injected with trypan blue. A: Brightfield image of follicle-enclosed oocytes at 48 
hours after tamoxifen treatment.  B: Trypan blue fluorescence in the same oocytes. C: 
GFP fluorescence showing blood vessels. Note deterioration of ovarian follicles 









Fig. 25. Effect of Tamoxifen (low dose) treatment on Tg(fli1:EGFP)y1 zebrafish  not 
injected with trypan blue. A: Brightfield image of follicle-enclosed oocytes at 48 
hours after tamoxifen treatment.  B: No fluorescence is evident in the trypan blue 
fluorescence channel. C: GFP fluorescence showing blood vessels. Note deterioration 
of ovarian follicles (arrow). There is also a loss of blood vessels compared to control 









Fig. 26. Effect of tamoxifen (high dose) treatment on Tg(fli1:EGFP)y1 zebrafish. A: 
Brightfield image of follicle-enclosed oocytes at 48 hours after tamoxifen treatment.  
B: Trypan blue fluorescence in the same oocytes. C: GFP fluorescence showing 
blood vessels. Note deterioration of ovarian follicles (arrow) and the low trypan blue 










Fig. 27. Effect of tamoxifen (low dose) treatment on Tg(fli1:EGFP)y1 zebrafish at 
different time intervals. A-C 72 hours post treatment. D-F: 96 hours post treatment. 
G-I 8 days post treatment. A, D, G - Brightfield images of follicle-enclosed oocytes.  
B, E, H: Trypan blue fluorescence in the corresponding oocytes. C, F, I: GFP 
fluorescence showing blood vessels in the corresponding oocytes. Note deterioration 
of ovarian follicles (arrows) and the low trypan blue fluorescence. There is also a loss 
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Fig. 28. Temporal changes in follicle-enclosed oocytes of untreated casper 
zebrafish. Brightfield images of intact untreated casper zebrafish taken on the days 
indicated. Note natural cycling of the follicles between development and regression. 
Days at which follicles are fully developed versus regressed are marked. 
fully developed
ovarian follicles  
fully developed






Fig. 29. Analysis of temporal changes in follicle-enclosed oocytes of untreated casper
zebrafish. Follicle diameters measured every alternate day from brightfield images 
were plotted to show changes during a one-month period. The red bars indicate 
number of embryos spawned after crossing with male. The days during which the 
diameters remained low suggest regression occurring naturally and marked as 
“atresia”. X-axis denotes measurement dates. Y-axis denotes both follicle diameter 




















































































































































Fig. 30. Effect of tamoxifen on follicle-enclosed oocytes of casper zebrafish. 
Brightfield images of intact untreated casper zebrafish taken on at 16 days after 
treatment with tamoxifen (rows 2 and 3). Images in top row show changes in control 




Fig. 31. Reversal of tamoxifen- and estradiol-induced effects on casper zerbrafish. 
casper zebrafish treated with tamoxifen or estradiol for 15 days were moved to a 
tamoxifen- and estradiol-free tank. Brightfield images show follicle-enclosed oocytes 




Fig. 32. Effect of estradiol on casper zebrafish with developed follicle-enclosed 
oocytes. Brightfield images show changes in follicle-enclosed oocytes in intact casper
zebrafish treated with estradiol for 9 days. The images taken at different time points 
are as indicated.   
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Fig. 33. Effect of estradiol on casper zebrafish with regressed follicle-enclosed 
oocytes. Brightfield images show changes in follicle-enclosed oocytes in intact casper
zebrafish treated with estradiol for 9 days.  The images taken at different time points 




Fig. 34. Reversal of estradiol-induced effects on casper zerbrafish. casper zebrafish 
treated with estradiol for 15 days were moved to an estradiol-free tank. Brightfield 
images show changes in follicle-enclosed oocytes in casper zebrafish at different days 
during treatment and recovery in the hormone-free tank.  
Casper before E2  
Casper 7 days post E2  
Casper 15 days post E2  
Final day of E2 treatment 
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Fig. 35. Long term effect of estradiol on casper zebrafish. Brightfield images of an  
intact female casper zebrafish treated with estradiol for 28 days show the 






Fig. 36. Testis images from Tg(fli1:EGFP)y1 zebrafish. Brightfield images show 
different views of testis dissected from male Tg(fli1:EGFP)y1 zebrafish.  Note the 
presence of seminiferous tubules in the testis. Also note the presence of lipid 












Fig. 37. Ovarian follicles of casper zebrafish exposed to long term estradiol. Brightfield 
images of ovarian follicles from casper zebrafish exposed to estradiol for 28 days were 
taken at low (20x) and high (32x) magnifications. Note - at low magnification (top), a 
thick layer of adipose tissue that looks similar to a testis is seen. The images at high 
magnification (bottom) show the presence of previtellogenic follicles with germinal 
vesicles and small follicles (n = 3 fish)  
20 x 20 x 
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Fig. 38. Trypan blue localizes to yolk in zebrafish embryos. Brightfield (top) and 
fluorescence (bottom) images of embryos from trypan blue injected zebrafish show  
localization of trypan blue fluorescence in yolk (white arrow) and its complete 






Fig. 39. Trypan blue localization in the larval stage of zebrafish embryos. Brightfield 
(top left) and fluorescence (top right and bottom) images of larval stage embryos from 
trypan blue injected Tg(fli1:EGFP)y1 zebrafish show localization of trypan blue (red) 
fluorescence in yolk and its complete exclusion from other parts of the developing 







Fig. 40. Confocal microscopy of trypan uptake into oocytes. Optical sections of 
oocytes dissected from Tg(fli1:EGFP)y1 were obtained using confocal microscopy 
and show fluorescence of trypan blue (red) and nuclear stain Hoeschst (blue). A, B. 
Images show two different optical sections of oocytes dissected at 21 hours post 
trypan blue injection. C. Image shows an optical section of oocytes dissected at 44 
hours post trypan blue injection. Note trypan blue fluorescence is located in 






Fig. 41. Confocal microscopy of trypan uptake into Tg(fli1:EGFP)y1 oocytes. Z-axis 
projection of oocytes dissected from Tg(fli1:EGFP)y1 5 days after trypan blue 
injection. The projection was reconstructed using optical sections from a confocal 
microscope. Trypan blue fluorescence appears red, nuclear stain in blue, and vascular 
GFP fluorescence in green.  
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